ArticleCell reports. Medicine2026
Functional human salivary gland organoids for tissue regeneration in chemically defined culture systems.
Article in Cell reports. Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Regenerative therapies for salivary gland dysfunction remain unavailable. We establish a fully chemically defined, xeno-free three-dimensional culture system to generate functional human salivary gland organoids. These organoids recapitulate the typical glandular architecture and display multilineage cellular composition, supporting long-term expansion with high transcriptomic fidelity to the primary tissue. The organoids exhibit key salivary functions, including glycoprotein secretion, amylase expression, and calcium flux in response to cholinergic stimulation. Single-cell transcriptomic analysis reveals preserved epithelial heterogeneity within the organoids and indicates a basal-to-ductal-to-acinar bifurcated differentiation trajectory. In the orthotopic transplantation model using non-obese diabetic mice with Sjögren syndrome, the organoids significantly improve salivary secretion. In the ectopic subrenal capsule transplantation model using immunodeficient mice, the organoids achieve glandular tissue reconstruction and vascularization. This study establishes a robust, functionally mature, and clinically translatable human salivary gland organoid system as a platform for tissue regeneration therapies targeting salivary hypofunction disorders such as Sjögren syndrome.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.